Neogen (NASDAQ:NEOG) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Neogen (NASDAQ:NEOG) released its earnings results on Friday. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.12, Briefing.com reports. The firm had revenue of $231.30 million during the quarter, compared to analyst estimates of $227.16 million. Neogen had a negative net margin of 2.58% and a positive return on equity of 2.80%. During the same quarter last year, the business earned $0.11 EPS. The business’s revenue was up .7% on a year-over-year basis. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Down 5.4 %

NASDAQ:NEOG opened at $12.36 on Friday. Neogen has a one year low of $11.46 and a one year high of $18.75. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.79 and a current ratio of 4.41. The firm has a market cap of $2.68 billion, a P/E ratio of -112.36 and a beta of 1.23. The firm has a 50-day simple moving average of $13.54 and a 200-day simple moving average of $15.11.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Guggenheim assumed coverage on shares of Neogen in a report on Thursday, December 19th. They set a “buy” rating and a $15.00 price objective for the company. StockNews.com upgraded shares of Neogen to a “sell” rating in a report on Monday, September 30th.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.